DE SB55

Allows Delaware institutions of higher education (colleges and universities) to acquire, stock, and make available epinephrine autoinjectors for emergency use in treating anaphylaxis on campus

Permits trained employees or agents of higher education institutions to administer epinephrine autoinjectors or provide them for self-administration to anyone experiencing anaphylaxis, even without a prior allergy diagnosis or prescription

Requires employees administering epinephrine to complete a training program covering recognition of severe allergic reactions, proper storage and administration techniques, and emergency follow-up procedures, with certification valid for 2 years

Provides immunity from civil liability, criminal liability, and professional disciplinary action for health-care providers, pharmacists, institutions, and trained individuals who prescribe, dispense, or administer epinephrine autoinjectors in good faith and with reasonable care

Requires institutions to report each epinephrine administration incident to the Department of Health and Social Services, which must file an annual report to the General Assembly summarizing incidents and participation